Tango Therapeutics, Inc. SEC filings TNGX
Tango Therapeutics, Inc. has 424 filings in SEC EDGAR's recent list, going back to Jul 30, 2020. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 10, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| D | Filing | Oct 28, 2025 | — |
| EFFECT | Filing | May 21, 2025 | — |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| CORRESP | Letter to the SEC | May 19, 2025 | — |
| DEFR14A | Filing | Apr 24, 2025 | — |
| EFFECT | Filing | Sep 11, 2023 | — |
| CORRESP | Letter to the SEC | Sep 7, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2023 | — |
| D | Filing | Aug 24, 2023 | — |
| EFFECT | Filing | Sep 28, 2022 | — |
| EFFECT | Filing | Sep 12, 2022 | — |
| CORRESP | Letter to the SEC | Sep 8, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2022 | — |
| EFFECT | Filing | Mar 31, 2022 | — |
| EFFECT | Filing | Sep 29, 2021 | — |
| CORRESP | Letter to the SEC | Sep 27, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2021 | — |
| SEC STAFF LETTER | Filing | Jul 16, 2021 | — |
| EFFECT | Filing | Jul 16, 2021 | — |
| CORRESP | Letter to the SEC | Jul 15, 2021 | — |
| CORRESP | Letter to the SEC | Jul 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 23, 2021 | — |
| CORRESP | Letter to the SEC | Jun 17, 2021 | — |
| UPLOAD | Letter from the SEC | May 17, 2021 | — |
| 425 | Current report | Apr 14, 2021 | — |
| CERT | Filing | Sep 3, 2020 | — |
| EFFECT | Filing | Sep 2, 2020 | — |
| 8-A12B | For registration of certain classes of securities | Sep 2, 2020 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TNGX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1819133
- Former names
- BCTG Acquisition Corp. (until Aug 9, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.